| # | Country | Total Patents | |
|---|---|---|---|
| #1 | Australia | 8 | |
| #2 | United Kingdom | 6 | |
| #3 | WIPO (World Intellectual Property Organization) | 5 | |
| #4 | EPO (European Patent Office) | 3 | |
| #5 | Canada | 2 | |
| #6 | Israel | 2 | |
| #7 | New Zealand | 2 | |
| #8 | Brazil | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Agriculture |
| # | Technology | |
|---|---|---|
| #1 | Peptides | |
| #2 | Medical preparations | |
| #3 | Therapeutic chemical compounds | |
| #4 | Animal care | |
| #5 | Microorganisms |
| # | Name | Total Patents |
|---|---|---|
| #1 | Lewis Claire | 20 |
| #2 | Staton Carolyn | 17 |
| #3 | Robinson Jeffery | 5 |
| #4 | Robinson Jeffrey | 1 |
| #5 | Lewia Claire | 1 |
| Publication | Filing date | Title |
|---|---|---|
| AU2006200576A1 | Anti-angiogenic peptides | |
| GB0217018D0 | Peptide 1 | |
| GB0217015D0 | Peptide 4 | |
| GB0217017D0 | Peptide 2 | |
| GB0217014D0 | Peptide 3 | |
| GB0203883D0 | Peptide | |
| GB0203882D0 | Peptide variants | |
| CA2420765A1 | Anti-angiogenic peptides | |
| NZ532690A | Anti-angiogenic polypeptides | |
| IL152697D0 | Anti-angiogenic polypeptides |